金吾财讯 | 翰森制药(03692)股价走高,截至发稿,涨4.08%,报25.5港元,成交额6307万港元。消息面上,汇丰研究发研报指,翰森制药在强劲的产品销售和业务拓展(BD)带动下,去年下半年财报略微超出该行预期。该行预期公司长期销售可持续录得双位数增长,并推出创新产品及提升产能。维持“买入”评级,目标价由22港元上调至24.2港元。交银国际指出,翰森制药24年收入和净利润分别增长21.3%/...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.